View

The Vitalist Declaration

01
Life and health are good.
Death is humanity’s core problem, and aging its primary agent.
02
Aging causes immense suffering, and obviating it is scientifically plausible.
03
Humanity should apply the necessary resources to reach freedom from aging as soon as possible.
04
I will work on or support others to work on reaching unlimited healthy human lifespan.
05
I will carry the message against aging and death.
Vitalism's plan is clear and simple
01
Unify all who agree with the Vitalist Declaration
02
Spark an ecosystem of Vitalist individuals and organizations
03
Reach 1% of global GDP to fight aging. 

Join some Vitalist projects

Vitalist Bay: The biggest longevity event in the world

Physical proximity is a key to change, and one day every major city will have a thriving Vitalist community. To accelerate this trend, we launched the Vitalist Bay longevity zone in Berkeley, California, 2025. Eight conferences over eight weeks, bringing together the greatest minds in the world to address aging.

The longevity zone brought together well over a thousand Vitalists to one location, which served as a scientific crucible for acceleration as well as a health optimization venue.

In 2026, Vitalist Bay will be held in Berkeley again, bigger and better than ever before. Join the top minds in workshops, talks, longevity experiments and more, all while optimizing your health.

Frontier Health - a working group identifying regulatory opportunities for acceleration

Frontier Health is a platform we are incubating to enable access to novel interventions, enabled by regulatory innovation, while educating and streamlining the process for physicians, drug-makers and patients.

The effort was inspired by Montana's Right to Try expansion law, passed in 2023 and making it possible for any Montana doctor can prescribe any intervention that passed Phase 1 trials to any person who gives informed consent.

In Montana, there are three key hurdles to make this process work. First, finding drugs where the IP holder is willing to license usage in Montana. Second, securing a way to produce or access the drug in Montana, possibly with local manufacturing. Third, empowering physicians to deliver the drug to patients through training and education.

We are Mobilized Vitalists

"Vitalism is the first movement that combines ethical clarity with practical strategy. Finally a philosophically sound effort to get behind."

Patrick Linden, PhD

"Vitalism is the powerful and positive social movement that the fight against aging and death deserves."

Emil Kendziorra, MD

"In a world where people often make a virtue of suffering and death, Vitalism is a ray of hope for all who care about life and health."

Cat Thu Nguyen Huu

Contributor @ VitaDAO

"Aging and death are clearly undesirable, and it’s essential that we collaborate and align our efforts to bring aging under control. The more organizations and people unite under this philosophy, the more likely we are to succeed in this mission."

Aubrey de Grey

President and CSO
LEV Foundation

"Vitalism is a unity movement that everyone can agree on regardless of nationality, religion, or politics. The longevity biotech  revolution to maximise healthy lifespan will be a profound step change in human flourishing, but the field remains tragically neglected — join the movement!”

Sebastian Brunemeier

“Vitalism is the unifying ideology the longevity world desperately needs. It makes it clear we are all fighting for our lives and should act accordingly.”

Kai Micah Mills

Founder @ Cryopets

"We undertake this mission to solve aging alongside incredible, hard working, talented, and genuinely altruistic people — people in this community. I proudly work with the Vitalist community."

Mark Hamalainen

Co-founder @ LBF

"I have worked with many longevity-oriented organizations over decades.  Vitalism is the first I've seen able to bring passion together with expertise to create a unique 'force of human nature' that can take aging head-on."

Kevin Perrott, PhD

CEO @ OpenCures

"I think organizations should become Vitalist to differentiate themselves as hardcore. It’s important to differentiate yourself; otherwise, you don’t know what company you’re keeping."

FAQ

Common Questions

What makes Vitalism different from other longevity initiatives?

We are the only organization focused building an influence network to drive change.

Why do we need this? Aren't longevity science & technology already on a path to success?

No. The resources and attention dedicated to longevity today are a tiny fraction of what they could be, especially given the seriousness of the problem of aging. Current initiatives, often even according to their creators, are not going to yield major lifespan gains.

Aren't Special Economic Zones and Charter Cities sufficient?

Special Economic Zones and Charter Cities are important for longevity, but they are also vulnerable to the arbitrary decisions of the greater jurisdictions in which they operate. Most such jurisdictions are limited in capital attractiveness, and maturity, limiting their effectiveness.

I live outside the US/Europe? Can I still get involved?

Absolutely, we intend to spread Vitalism in every corner of the world.

Why not lobby and influence through traditional political campaigns?

We support lobbying as one of multiple measures. One challenge is that without a core and consistent voting constituency as well as concomitant economic interests and systematic coordination with for profit and non-profit stakeholders, any political support may be ephemeral. Additionally, lobbying efforts are often only able to reach a small group of leaders and cannot effect deep and wide systemic change.

Don’t we have enough money for longevity? Capitalism will solve longevity!

No. Longevity only gets less than 1% of biotech venture capital despite aging being the primary driver of healthcare costs. For a problem of this magnitude, humanity should be dedicating at least 1% of global GDP (~$1 Trillion), which is around 1000x more than what is being invested in fighting aging today. Despite spending around $11B in the last 25 years on various longevity companies, we yet to see ameaningful inflection in overall funding and attention.